文献速递复苏、休克与脓毒症创伤与烧伤

冷冻血小板细胞外囊泡作为失血性休克治疗剂的先导研究:大鼠模型

Pilot study of frozen platelet extracellular vesicles as a therapeutic agent in hemorrhagic shock in rats.
PubMed 文献 · J Trauma Acute Care Surg · 2023-11-27
一句话结论在大鼠非控制性失血性休克模型中,给予血小板细胞外囊泡(PEVs)较乳酸林格液(LR)降低死亡率(0% vs 36%,p=0.03)并改善平均动脉压(MAP)。

背景:失血是创伤后最可预防的死亡原因,血小板因保存期短和需冷藏而构成后勤挑战,血小板来源细胞外囊泡(PEVs)可能作为血小板替代品。方法:雄性大鼠麻醉后股血管置管,行剖腹术并切除中叶50%肝脏、纱布填塞,伤后立即接受2 mL PEVs或LR,6分钟内输注;用预称重纱布在5、15、30、45、60分钟量化腹腔出血,伤后1小时关腹,监测3小时后处死。结果:纳入21只大鼠(LR组11只,PEV组10只),总出血量6–10 mL且两组无显著差异;LR组死亡率36%,PEV组0%(p=0.03);LR组1小时乳酸显著更高(p=0.025);PEV组在15、45、60、180分钟MAP显著高于LR组。结论:基于生存和血流动力学改善,PEVs在非控制性失血性休克中的潜在应用早期研究令人鼓舞。

要点

  • 在非控制性失血性休克大鼠模型中,PEV组死亡率为0%,LR组为36%(p=0.03)。
  • PEV组在15、45、60、180分钟MAP显著高于LR组。
  • LR组1小时乳酸显著高于PEV组(p=0.025)。
  • 两组总出血量在6 mL至10 mL之间,无显著差异。
  • 作者认为,基于生存和血流动力学改善,PEVs在非控制性失血性休克中的潜在应用早期研究令人鼓舞。

适用人群与场景

  • 雄性大鼠非控制性失血性休克模型:麻醉后股血管置管,行剖腹术并切除中叶50%肝脏、纱布填塞。
  • 伤后立即接受2 mL PEVs或乳酸林格液(LR),6分钟内输注。

处置流程与药物剂量

  • 伤后立即经静脉输注2 mL PEVs或LR,6分钟内完成。
  • 伤后5、15、30、45、60分钟用预称重纱布量化腹腔出血。
  • 伤后1小时关腹,监测3小时后处死。

研究设计与关键结果

  • 先导研究:21只雄性大鼠(LR组11只,PEV组10只),比较PEVs与LR在非控制性失血性休克模型中的疗效。
  • 总出血量6–10 mL,两组无显著差异。
  • LR组死亡率36%,PEV组0%(p=0.03)。
  • LR组1小时乳酸显著高于PEV组(p=0.025)。
  • PEV组在15、45、60、180分钟MAP显著高于LR组。

证据类型、等级与局限

  • 证据类型:先导研究(动物实验,大鼠模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,基于生存和血流动力学改善,PEVs在非控制性失血性休克中的潜在应用早期研究令人鼓舞。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Hemorrhage accounts for the most preventable deaths after trauma. Resuscitation is guided by studies that demonstrate improved outcomes in patients receiving whole blood or balanced administration of blood products. Platelets present a logistical challenge due to short shelf life and need for refrigeration. Platelet-derived extracellular vesicles (PEVs) are a possible platelet alternative. Platelet-derived extracellular vesicles are secreted from platelets, have hemostatic effects and mitigate inflammation and vascular injury, similar to platelets. This pilot study aimed to elucidate the therapeutic effects of PEVs in a rat model of uncontrolled hemorrhage.

METHODS: Male rats were anesthetized and femoral vessels cannulated. Vital signs (MAP, HR, and RR) were monitored. Electrolytes, lactate and ABG were obtained at baseline, 1-hour and 3-hours post injury. Laparotomy was performed, 50% of the middle hepatic lobe excised and the abdomen packed with gauze. Rats received 2 mL PEVs or lactated Ringers (LR) over 6 minutes immediately after injury. Peritoneal blood loss was quantified using preweighed gauze at 5 minutes, 15 minutes, 30 minutes, 45 minutes, and 60 minutes. Laparotomy was closed 1-hour postinjury. Animals were monitored for 3 hours postinjury then euthanized. Generalized Linear Mixed Effects models were performed to assess effects of treatment and time on lactate and MAP.

RESULTS: Twenty-one rats were included (11 LR, 10 PEV). Overall blood loss was between 6 mL and 10 mL and not significantly different between groups. There was a 36% mortality rate in the LR group and 0% mortality in the PEV group ( p = 0.03). The LR group had significantly higher lactates at 1 hour ( p = 0.025). At 15 minutes, 45 minutes, 60 minutes, and 180 minutes, the MAP of the PEV group was significantly higher than the LR group.

CONCLUSION: Early studies are encouraging regarding the potential use of PEVs in uncontrolled hemorrhagic shock based on improved survival and hemodynamics.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Durbin S, Loss L, Buzzard L, et al. Pilot study of frozen platelet extracellular vesicles as a therapeutic agent in hemorrhagic shock in rats. J Trauma Acute Care Surg. 2023. PMID: 38011031. doi:10.1097/TA.0000000000004210

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。